Searchable abstracts of presentations at key conferences in endocrinology

ea0038p6 | Bone | SFEBES2015

Increased circulating sclerostin levels in type 2 diabetic rats are not associated with changes in bone sclerostin production

Pereira Marie , Gohin Stephanie , Lund Nina , Hvid Anne , Smitham Peter , Oddy Michael , Reichert Ines , Chenu Chantal

Type 2 Diabetes Mellitus (T2DM) is associated with decreased bone quality and a higher prevalence of fractures. Sclerostin is an inhibitor of bone formation produced by osteocytes and its expression is elevated in serum of diabetic patients. We examined the effect of T2DM on bone architecture and sclerostin levels in a rat model of T2DM and the influence of hyperglycaemia on sclerostin production by bone cells in vitro. Bone architecture was measured by microCT in 14 ...

ea0037gp.26.01 | Thyroid – hypothyroidism | ECE2015

Quality of life in primary hypothyroidism after long-term levothyroxine replacement

Djurovic Marina , Pereira Alberto , Vasovic Olga , Jemuovic Zvezdana , Pavlovic Dragan , Petakov Milan , Salak Biljana , Damjanovic Svetozar

Introduction: There is an increasing awareness for intrinsic imperfections of endocrine replacement therapy affecting general well-being in the long-term. For thyroid hormone, many factors affect the variable responses to hormone replacement, like common genetic variations in deiodinase and thyroid hormone transport proteins, and the inability to provide adequate individual combined T4 and T3 therapy. Despite levothyroxine (L-T4)...

ea0037ep436 | Diabetes (complications & therapy) | ECE2015

Stroke in prediabetic patients

Silva-Fernandez Julia , Garcia-Ruiz Rafael , Moreno-Moreno Paloma , Garcia-Ruiz Rosa Maria , Gonzalez-Pereira Carolina

Objective: To describe the clinical characteristics of stroke in patients with prediabetes mellitus (pre-DM) and to compare them with DM and non-DM patient characteristics.Methods: Retrospective analysis of a prospective series of acute stroke patients. Demographic and clinical characteristics were compared among the three groups, along with outcome data. Stroke severity was evaluated by modified Rankin scale (mRS) and NIHSS (NIH stroke scale).<p cla...

ea0037ep459 | Diabetes (complications &amp; therapy) | ECE2015

Risk factors, aetiology, and prognosis in patients with ischaemic stroke and diabetes mellitus

Silva-Fernandez Julia , Garcia-Ruiz Rafael , Moreno-Moreno Paloma , Garcia-Ruiz Rosa M , Gonzalez-Pereira Carolina

Objective: To describe the clinical, aetiological and prognostic differences in diabetic and non-diabetic ischaemic stroke (IS) patients.Materials and methods: Retrospective analysis of prospective series of IS patients. Patients were classified as non-DM and DM patients. Demographic and clinical characteristics were compared between two groups. IS prognosis was evaluated by modified Rankin scale (mRS) and NIHSS (NIH stroke scale)....

ea0037ep724 | Pituitary: clinical | ECE2015

Serum cortisol in the early postoperative period as predictor of remission in Cushing's disease

Oliveira Joana , Lau Eva , Belo Sandra , Freitas Paula , Vinha Eduardo , Pereira Josue , Castro Ligia , Carvalho Davide

Introduction: Pituitary surgery is currently considered the preferred treatment for Cushing’s disease (CD) and achieves remission in 55–85% of patients. Cortisol falls quickly after surgery, so that early post-operative cortisol level has been used as predictor of remission. There’s no agreement about optimal timing for cortisol measurement, with wide variability between centres.Objective: To assess the value of early post-operative serum ...

ea0037ep725 | Pituitary: clinical | ECE2015

Predictive factors for remission and recurrence in Cushing's disease: a single-centre study

Oliveira Joana , Lau Eva , Belo Sandra , Freitas Paula , Vinha Eduardo , Pereira Josue , Castro Ligia , Carvalho Davide

Introduction: Cushing’s disease (CD) is characterised by pathologic hypercortisolism caused by an ACTH-secreting pituitary adenoma. The primary modality for definitive treatment is pituitary surgery. The rarity of CD has made it difficult to establish reliable predictive factors of outcomes.Aim: Assessment of clinical, hormonal, radiological, surgical and histological findings as predictors of remission and relapse of CD.Metho...

ea0037ep749 | Pituitary: clinical | ECE2015

The development and validation of a new burden and needs assessment questionnaire for patients with pituitary diseases: the BNQ-pituitary

Andela Cornelie , Scharloo Margreet , Ramondt Steven , Tiemensma Jitske , Kaptein Ad , Pereira Alberto , Kamminga Noelle , Biermasz Nienke

Background: An increasing number of studies assess quality of life (QoL) in patients with pituitary diseases. At present, available disease-specific QoL questionnaires do not completely cover the patient perspective of QoL. Furthermore, there are no disease-specific questionnaires available which inventories patient’s needs for help for impairments in QoL.Objective: To develop and validate a disease-specific QoL questionnaire for patients with pitui...

ea0037ep865 | Thyroid cancer | ECE2015

Incidental papillary thyroid carcinoma prevalence in benign multinodular goitre: data from Northern Portugal

Pereira Maria Teresa , de Carvalho Andre Couto , Freitas Claudia , Borges Fatima

Introduction: Incidental papillary thyroid carcinoma (PTC) in patients undergoing thyroidectomy for benign multinodular disease is a well-recognised finding. Its true prevalence remains uncertain and shows great variability between studies, ranging from 7–25%. Our purpose was to review the prevalence of PTC in thyroid glands removed for benign nodular disease at a Northern Portuguese tertiary hospital.Methods: From December 2012 to December 2014, th...

ea0037ep1243 | Clinical Cases–Pituitary/Adrenal | ECE2015

Acromegaly caused by atypical pituitary adenoma

Costa Maria Manuel , Saavedra Ana , Castro Ligia , Basto Margarida , Pereira Josue , Vinha Eduardo , Carvalho Davide

Introduction: Atypical pituitary adenomas have higher risk of aggressive behaviour in particular by the higher growth, local invasion and high risk of recurrence after surgery. In acromegaly the resistance to somatostatin analogues may be another manifestation of these adenomas since higher levels of Ki-67 are associated with poor response to therapy.Case report: A 41-year-old woman presented to our consult with history of headaches, growth of the hands,...

ea0035p53 | Adrenal cortex | ECE2014

Clinical characteristics and follow-up of patients with adrenal incidentalomas

Fernandes Vera , Santos Maria J , Pereira Maria L , Alves Marta , Souto Selma , Marques Olinda

Background: The adrenal incidentalomas (AI), adrenal masses ≥10 mm in diameter incidentally detected, have increased their prevalence due to technological advances in imaging. The adrenalectomy is indicated in functioning adrenal tumors and in cases suspected of malignancy.Objectives: To analyze the characteristics of patients with AI and to evaluate the clinical outcome, in terms of evolution toward hypersecretion and significant growth, during fo...